(Q47993571)

7 February 2018

title

Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. (English)

1 reference

7 February 2018

1 reference

1 reference

5

1 reference

7 February 2018

Alastair Burt

6

1 reference

7 February 2018

author name string

B C Smith

1

1 reference

7 February 2018

J Gorve

2

1 reference

7 February 2018

M A Guzail

3

1 reference

7 February 2018

C P Day

4

1 reference

7 February 2018

M F Bassendine

7

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 June 1998

1 reference

7 February 2018

published in

Hepatology

1 reference

7 February 2018

volume

27

1 reference

7 February 2018

issue

6

1 reference

7 February 2018

page(s)

1695-1699

1 reference

7 February 2018

Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

Clinical outcomes after transfusion-associated hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

Liver iron concentration in chronic viral hepatitis: a study of 98 patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

Measurements of iron status in patients with chronic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

Response to interferon alpha therapy is influenced by the iron content of the liver

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

Serum aminotransferase levels as an indicator of the effectiveness of venesection for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

Changes in serum iron levels due to infection with hepatitis B virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

Hepatitis B virus infection markers in genetic haemochromatosis. A study of 272 patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

Iron withholding: a defense against infection and neoplasia

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

Liver damage in Italian patients with hereditary hemochromatosis is highly influenced by hepatitis B and C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

Putting a hold on "HLA-H'. The WHO Nomenclature Committee for Factors of the HLA System

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

Haemochromatosis and HLA-H

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

A simple genetic test identifies 90% of UK patients with haemochromatosis. The UK Haemochromatosis Consortium

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

Haemochromatosis and HLA-H.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

The frequency of hemochromatosis-associated alleles is increased in British patients with sporadic porphyria cutanea tarda

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

Genetic irony beyond haemochromatosis: clinical effects of HLA-H mutations

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

Histological grading and staging of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

Long-term consequence of rat orthotopic liver transplantation with and without hepatic arterial reconstruction: a clinical, pathological, and hemodynamic study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

Clinical and biochemical abnormalities in people heterozygous for hemochromatosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

Identification of homozygous hemochromatosis subjects by measurement of hepatic iron index

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

Hemosiderosis in cirrhosis: a study of 447 native livers

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

Liver fibrosis in genetic hemochromatosis. Respective roles of iron and non-iron-related factors in 127 homozygous patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

Experimental liver cirrhosis induced by alcohol and iron

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis B and C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

Pathogenesis of hepatic fibrosis in experimental iron overload

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

Serum ferritin as a predictor of host response to hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

The critical role of iron in some clinical infections

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

Iron and chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

Lipid peroxidation and associated hepatic organelle dysfunction in iron overload

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

The effect of iron overload on rat plasma and liver oxidant status in vivo

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

Body iron stores and the risk of cancer

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270631

7 January 2021

Identifiers

DOI

10.1002/HEP.510270631

1 reference

7 February 2018

release_w6mqe6wmxvh6bhrayzbuamzxwy

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/w6mqe6wmxvh6bhrayzbuamzxwy

24 November 2022

mapped directly with Wikidata item

1 reference

7 February 2018